AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
3.200
+0.050 (1.59%)
At close: Jun 13, 2025, 4:00 PM
3.260
+0.060 (1.87%)
Pre-market: Jun 16, 2025, 8:36 AM EDT
AbCellera Biologics Employees
AbCellera Biologics had 596 employees as of December 31, 2024. The number of employees increased by 10 or 1.71% compared to the previous year.
Employees
596
Change (1Y)
10
Growth (1Y)
1.71%
Revenue / Employee
$38,782
Profits / Employee
-$281,658
Market Cap
955.15M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
ABCL News
- 16 days ago - AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575 - Business Wire
- 4 weeks ago - AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause - Business Wire
- 4 weeks ago - AbCellera's Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit - Business Wire
- 5 weeks ago - AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting - Business Wire
- 5 weeks ago - AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - AbCellera Reports Q1 2025 Business Results - Business Wire
- 6 weeks ago - AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025 - Business Wire
- 2 months ago - AbCellera to Participate at Upcoming Investor Conferences in May and June - Business Wire